NYSE Big Stage: Ecolab Takes a Hands-on Approach to Hospital Superbugs | March 2014
Mar 16, 2014
This NYSE Big Stage feature article details Ecolab's innovative approach to helping ensure hand hygiene and addressing viruses and bacteria like influenza, norovirus, C. difficile, staph, MRSA and VRE. The article explains the relevancy of recent Ecolab products including Nexa and Oxycide as well as comprehensive training and education programs.
Read the full article here.